{"id":47819,"date":"2022-08-30T22:01:39","date_gmt":"2022-08-30T20:01:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/"},"modified":"2022-08-30T22:01:39","modified_gmt":"2022-08-30T20:01:39","slug":"team-synapse-takes-on-grueling-blue-ridge-relay","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/","title":{"rendered":"Team Synapse Takes On Grueling Blue Ridge Relay"},"content":{"rendered":"
\n

\n12 Runners Living With Parkinson<\/b>\u2019s Disease <\/b>Raising Awareness, Funds And Inspiring Others To Exercise<\/b>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–#Blueridgerelay<\/a>–Twelve dedicated runners, all living with Parkinson\u2019s Disease (PD), will take on one of the most grueling relay road races in the US –\u2013 the 208-mile Blue Ridge Relay (BRR) on September 9-10.\n<\/p>\n

<\/a><\/p>\n

\nThe Team Synapse<\/a> runners, despite the many physical limitations from PD, have only 35 hours to finish the race. They will confront 17,000 feet of ascent and must average a 10-minute mile pace to meet the race time limits. The race is from Virginia to North Carolina in the picturesque Blue Ridge Mountains.\n<\/p>\n

\nEach runner takes on three of 36 race segments. Segments average six miles, so each runner will run approximately 18 miles. The race is non-stop, so in addition to PD, the team will have to carefully manage meals, hydration, physical recovery, and sleeping minutes to beat the time limit.\n<\/p>\n

\nTeam Synapse\u2019s purpose is to raise awareness and funds to help find a cure for PD. It also wants to inspire those with Parkinson\u2019s to exercise, the only way to slow the progression of the disease. Team Synapse is organized by not-for-profit Uncorked Adventures whose mission is to help people live better with PD while working together to find a cure.\n<\/p>\n

\nPutting together a team of 12 runners, all living with PD, to take on this grueling endeavor is truly unprecedented.\u201d says Bill Bucklew who leads Uncorked Adventures. \u201cWe combed our network of dedicated and relentless athletes, tapping into their inspirational missions. We feel like we have assembled a \u201cdream team.\u201d\n<\/p>\n

\nTeam Synapse features runners with backgrounds that include an American Ninja Warrior and her fianc\u00e9, a pilot and even a chef. The team includes Rhonda Foulds, Bill Bucklew, Joe Drake, Peter Leech, Christopher Lion, Renee Trent, Jacqui Sukie, Scott Fernandez, Jared Koch, Janet Vickers, Greg O\u2019Keefe, Jason Kopacz, Steven Eury and alternate Allison Toepperwein. The team comes from across the US.\n<\/p>\n

\nThe team\u2019s name highlights how PD inhibits synaptic communications between the brain and body. This leads to motor control problems like tremors, so by strengthening the synapses, the communication gap can be closed. The name also means raising money to help close the gap between fundraising and finding a cure for Parkinson\u2019s.\n<\/p>\n

\n\u201cWe are honored to have Team Synapse focus on inspiration, awareness and fundraising to support research to find a cure,\u201d says Liz Diemer, Vice President, Community Fundraising at Team Fox of The Michael J. Fox Foundation<\/a>. \u201cThe Team is giving so much of themselves physically and emotionally to support the Foundation\u2019s efforts to find a cure for Parkinson\u2019s.\u201d\n<\/p>\n

\n\u201cThis relay team is such a great metaphor for life, showing how we all can accomplish so much more working together. It\u2019s also so important for people living with neurodegenerative diseases like Parkinson\u2019s to exercise regularly,\u201d says Bucklew. \u201cWe hope to raise significant research funds towards finding a cure, while inspiring people to stay active.\u201d\n<\/p>\n

\nParkinson\u2019s Disease is the fastest growing neurodegenerative disease. More than one million people in the U.S. are living with the disease. This number is expected to double by 2040 and approximately 60,000 Americans are diagnosed with PD each year.\n<\/p>\n

\n\u201cThe demand for better treatments and a cure is increasingly critical. While there\u2019s no cure for Parkinson’s, research suggests that exercise is one of the best things for your mind and body,\u201d says Bucklew. \u201cThe stage is set for an epic endeavor, and we can\u2019t wait to conquer the Blue Ridge Relay.\u201d\n<\/p>\n

\nTo support Team Synapse: Donate Here<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nBill Bucklew<\/a>
wbucklew@gmail.com<\/a>\n<\/p>\n

\nKevin Donnellon<\/a>
kevin.donnellon@macalicomm.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

12 Runners Living With Parkinson\u2019s Disease Raising Awareness, Funds And Inspiring Others To Exercise CHICAGO–(BUSINESS WIRE)–#Blueridgerelay–Twelve dedicated runners, all living with Parkinson\u2019s Disease (PD), will take on one of the most grueling relay road races in the US –\u2013 the 208-mile Blue Ridge Relay (BRR) on September 9-10. The Team Synapse runners, despite the many … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47819","6":"format-standard","7":"category-industry"},"yoast_head":"\nTeam Synapse Takes On Grueling Blue Ridge Relay - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Team Synapse Takes On Grueling Blue Ridge Relay - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"12 Runners Living With Parkinson\u2019s Disease Raising Awareness, Funds And Inspiring Others To Exercise CHICAGO–(BUSINESS WIRE)–#Blueridgerelay–Twelve dedicated runners, all living with Parkinson\u2019s Disease (PD), will take on one of the most grueling relay road races in the US –\u2013 the 208-mile Blue Ridge Relay (BRR) on September 9-10. The Team Synapse runners, despite the many ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-30T20:01:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220829005741\/en\/1556472\/21\/brr_lr.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Team Synapse Takes On Grueling Blue Ridge Relay\",\"datePublished\":\"2022-08-30T20:01:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/\"},\"wordCount\":615,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005741\\\/en\\\/1556472\\\/21\\\/brr_lr.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/\",\"name\":\"Team Synapse Takes On Grueling Blue Ridge Relay - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005741\\\/en\\\/1556472\\\/21\\\/brr_lr.jpg\",\"datePublished\":\"2022-08-30T20:01:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005741\\\/en\\\/1556472\\\/21\\\/brr_lr.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005741\\\/en\\\/1556472\\\/21\\\/brr_lr.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/team-synapse-takes-on-grueling-blue-ridge-relay\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Team Synapse Takes On Grueling Blue Ridge Relay\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Team Synapse Takes On Grueling Blue Ridge Relay - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/","og_locale":"en_US","og_type":"article","og_title":"Team Synapse Takes On Grueling Blue Ridge Relay - Pharma Trend","og_description":"12 Runners Living With Parkinson\u2019s Disease Raising Awareness, Funds And Inspiring Others To Exercise CHICAGO–(BUSINESS WIRE)–#Blueridgerelay–Twelve dedicated runners, all living with Parkinson\u2019s Disease (PD), will take on one of the most grueling relay road races in the US –\u2013 the 208-mile Blue Ridge Relay (BRR) on September 9-10. The Team Synapse runners, despite the many ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-30T20:01:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220829005741\/en\/1556472\/21\/brr_lr.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Team Synapse Takes On Grueling Blue Ridge Relay","datePublished":"2022-08-30T20:01:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/"},"wordCount":615,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005741\/en\/1556472\/21\/brr_lr.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/","url":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/","name":"Team Synapse Takes On Grueling Blue Ridge Relay - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005741\/en\/1556472\/21\/brr_lr.jpg","datePublished":"2022-08-30T20:01:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220829005741\/en\/1556472\/21\/brr_lr.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220829005741\/en\/1556472\/21\/brr_lr.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/team-synapse-takes-on-grueling-blue-ridge-relay\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Team Synapse Takes On Grueling Blue Ridge Relay"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47819"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47819\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}